Expand SNSE Menu
SNSE MENU

SNSE Latest Press Releases

-- June 15, 2026 --

Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer Business Wire 8:10 AM

-- June 4, 2026 --

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:00 PM

-- May 15, 2026 --

Sensei Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update Business Wire 7:30 AM

-- May 14, 2026 --

"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies Globe Newswire 10:55 AM

-- May 5, 2026 --

Sensei Biotherapeutics Doses First Patient in Phase 1b/2 Trial of PIKTOR in HR+/HER2- Advanced Breast Cancer Business Wire 7:30 AM

-- April 9, 2026 --

Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference Business Wire 7:30 AM

-- March 30, 2026 --

Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update Business Wire 7:30 AM

-- March 19, 2026 --

The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology Globe Newswire 11:00 AM

-- March 17, 2026 --

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 6:00 AM

-- February 25, 2026 --

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 6:00 AM

-- February 18, 2026 --

Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement Business Wire 8:00 AM
Market Data Delayed 15 Minutes